Related references
Note: Only part of the references are listed.Gastric marginal zone lymphoma of MALT type: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
E. Zucca et al.
ANNALS OF ONCOLOGY (2008)
Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy:: experience from a large international series
W. Fischbach et al.
GUT (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?
Pier Francesco Ferrucci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Marginal-zone lymphoma
Andres J. M. Ferreri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas
M Raderer et al.
GUT (2006)
Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue
Seth M. Cohen et al.
ONCOLOGIST (2006)
Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication
T Wündisch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment results in localized primary gastric lymphoma: Data of patients registered within the German Multicenter Study (GIT NHL 02/96)
P Koch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
State-of-the-art therapeutics: Marginal-zone lymphoma
F Bertoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H-pylori eradication.: Lack of association with translocation t(11;18):: a 10-year updated follow-up of a prospective study
C Montalban et al.
ANNALS OF ONCOLOGY (2005)
Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-helicobacter pylori therapy
G Martinelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series
W Fischbach et al.
GUT (2004)
Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma
C Copie-Bergman et al.
GUT (2003)
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type
A Conconi et al.
BLOOD (2003)
Paris staging system for primary gastrointestinal lymphomas
A Ruskoné-Fourmestraux et al.
GUT (2003)
Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: A retrospective study of patients treated during 1976-2001
C Thieblemont et al.
LEUKEMIA & LYMPHOMA (2003)
Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori
W Fischbach et al.
LANCET (2002)
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial
F Bertoni et al.
BLOOD (2002)
Gastric MALT lymphoma: from aetiology to treatment
MQ Du et al.
LANCET ONCOLOGY (2002)
Low-grade malt lymphoma of the stomach: A review of treatment options
NR Schechter et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
